Diagnosed with rare cancer, Fatin Umairah Azme needs your help
PETALING JAYA : Most 16-year-old girls spend their time with friends, chatting about music and movies or planning for life after high school.
But for Fatin Umairah Azme, the reality is far more challenging: she has been diagnosed with high-risk neuroblastoma. This is a rare and aggressive form of cancer that starts in cells called neuroblasts, or immature nerve cells.
Neuroblastoma often begins in the adrenal glands, which are located on top of the kidneys. It can also develop in the spine, abdomen, neck or chest.
Over time, the cancer cells can spread to other parts of the body – most commonly to the lymph nodes, liver, bone marrow, skin and bones.
Now, Fatin needs a life-saving immunotherapy drug called Qarziba, which would cost her family a staggering RM578,000.
Fatin's father, Azme Tomezi, said she began suffering from stomach pain in January 2023. Although her condition initially improved after visiting a clinic and taking medication, the pain would recur.
'In January 2024, it became unbearable. She couldn't sleep at night due to severe abdominal cramps. I had no choice but to take her to the hospital for scans,' Azme said.
After several tests, the doctors suspected cancer. But as the hospital lacked specialised care, Fatin was referred elsewhere.
In March last year, a biopsy was performed and Fatin was diagnosed with high-risk neuroblastoma. She began chemotherapy that same month.
Further examinations, however, revealed swollen lymph nodes in her neck and that the tumour had spread to her left adrenal gland and cervical region. In August, Fatin underwent surgery to remove the tumour.
During the procedure, the doctors discovered malignant growths along her intestinal wall and on her kidney, which were removed as well.
Initially, the doctors had planned to include a stem-cell transplant as part of Fatin's treatment. But they then discovered one of her kidneys had been damaged, making it too dangerous to proceed.
Fatin subsequently began radiotherapy, and her final session ended on March 7.
CCEP Foundation CEO Yvonne Yee is appealing to the public to help Fatin and her family in their time of need. (CCEP Foundation pics)
Today, Fatin weighs only 41kg. While this is a slight improvement from her lowest weight of 34kg, she remains very frail – and in need of urgent support.
The only viable option for her is immunotherapy, and Qarziba is her only hope. Unfortunately, the cost is far more than what her family can afford.
Azme is a production staff at an air-conditioner appliance company, while his wife is a homemaker. Fatin is the third of five siblings, all of whom are studying.
To raise funds, the family has reached out to CCEP Foundation, an NGO dedicated to assisting the needy, poor, deprived and underprivileged.
According to its CEO, Yvonne Yee, Fatin will need 25 to 30 vials of Qarziba, which will cost a total of RM578,000.
Speaking with FMT Lifestyle, Yee shared that the foundation began fundraising on June 30 and has only raised about RM3,000 so far.
'This overwhelming medical cost is unimaginable for Fatin's family. We sincerely appeal to the kindness of the public to come forward and help her fight this battle,' said Yee.
To help Fatin, donations can be made directly to CCEP Foundation, RHB Bank account number 2621 9300 009 342. Please use the reference 'Fatin'.
If you require a receipt, kindly send them a WhatsApp message.
To request a tax-exempt receipt, please fill out your details here. Receipts will be issued within 14 working days.
Learn more about CCEP Foundation here, or contact 03-7955 9999 / 010-279 8849.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
5 hours ago
- Malay Mail
Ipsos survey: Six in ten Malaysians welcome old age, outpacing global trend
KUALA LUMPUR, Aug 11 — Malaysians are more optimistic than the global average about entering their later years, with almost six in ten saying they look forward to old age, according to a new Ipsos survey. In its Malaysian Attitudes Towards Ageing 2025 survey, the global market research firm found that 58 per cent of Malaysians expressed a positive outlook towards ageing. That was well above the global average of 38 per cent and in line with other Southeast Asian nations. 'In developed countries, a longer life expectancy and a higher threshold for what is considered 'old age' do not translate into positive sentiment,' the firm noted. It added that enthusiasm rises with income, education, and perceived distance from old age. Ipsos suggested Malaysia's upbeat view of ageing is likely tied to cultural respect for elders and strong family and community support networks. Ipsos' Malaysian Attitudes Towards Ageing 2025 survey found 58pc of Malaysians view ageing positively, above the 38pc global average and similar to other Southeast Asian nations. — Screengrab courtesy of Ipsos Optimism is even higher in neighbouring Indonesia at 89 per cent and the Philippines at 74 per cent, while Thailand stands at 58 per cent and Singapore at 46 per cent. In contrast, only 30 per cent of Japanese respondents and 10 per cent of French respondents said they look forward to old age. Old age now begins at 60 That optimism is reflected in shifting perceptions of when old age starts. Malaysians now place the threshold at 60, compared to 56 in 2018 — a four-year increase unique in Southeast Asia. Indonesians put the mark at 59, Filipinos at 60, Singaporeans at 62, and Thais at 65. The global average is 66, with France topping the list at 72. Living longer than expected Malaysians believe they will live to an average of 74 years, slightly under the actual life expectancy of 75.2 years. This gap is narrower than in countries like Japan, where people expect to live to 80 years despite a life expectancy of 83.5 years. In Southeast Asia, Indonesia's life expectancy is 72.5 years and the Philippines' is 71.8 years. Ipsos noted that countries with higher life expectancy tend to be less optimistic about ageing, while those with lower life expectancy, such as Indonesia and the Philippines, are more positive. Investment needed for aged nation The firm warned that with Malaysia projected to become an 'aged nation' by 2043 — when 14 per cent of the population will be aged 65 and above — and the average Malaysian expected to spend 15 years in old age, greater investment in healthcare and social protection will be crucial to ensuring later years are lived with health, dignity and fulfilment. To note, the findings of the survey are based on interviews with a representative sample of adults aged under 75 across 32 countries, totalling around 23,745 respondents.
Malay Mail
9 hours ago
- Malay Mail
Zahid calls for fresh approach to combat drug abuse amid worrying rise in synthetic drugs
PUTRAJAYA, Aug 10 — A new, non-conventional approach is needed to combat drug abuse in the country, said Deputy Prime Minister Datuk Seri Dr Ahmad Zahid Hamidi. He said that a change in strategy was crucial because the current trend of drug abuse is very worrying, with an increase in the use of synthetic drugs and new distribution methods through social media platforms. 'The government has spent over RM50 billion on prevention, enforcement, and treatment, but the effect is that drug abuse is still on the rise. We must admit this failure... let's set aside our differences to ensure that even if the country cannot be 100 percent free of drug abuse, it is not impossible for us to reduce it to the bare minimum,' he said. He made these remarks while speaking at the opening ceremony of the 46th general assembly of the Malaysian Anti-Drug Association (Pemadam) last night. Ahmad Zahid also expressed concern that a report by the National Anti-Drug Agency (AADK) found that 68 percent of all drug abusers are young people aged between 19 and 39, including professionals. 'In the long run, this will reduce productivity, not to mention the country's assets... this young workforce is needed to contribute to all sectors in this country,' he said. He recommended that relevant enforcement agencies and Pemadam adopt an approach of increasing two-way communication with the target group to reduce this phenomenon. 'It's not just about giving lectures but becoming listeners who understand. Not just educating, but also immersing ourselves in the emotions of young people. We can't just rely on old approaches through lectures and distributing brochures. We must use a communication approach through digital technology,' he said. Ahmad Zahid also suggested that Pemadam create a digital communication team in every state, and empower training and advocacy modules for volunteers. In addition, he put forward the idea that an integrated information portal and a smart application should be developed, along with strengthening strategic cooperation with influencers and social media communities. — Bernama
Malay Mail
a day ago
- Malay Mail
InvestPenang pitches Penang as Asia's next top medtech hub
GEORGE TOWN, Aug 10 — Penang's medical technology (medtech) industry is rapidly emerging as one of the state's most promising sectors, driven by strong global demand, robust local capabilities, and a well-established ecosystem. InvestPenang chief executive officer Datuk Loo Lee Lian said the state's expertise in precision engineering and automation, developed through its thriving semiconductor industry, has been instrumental in the growth of the medtech sector in the state. 'In the semiconductor industry, precision and automation are essential, and these competencies translate directly into the production of surgical instruments, implants, and high-accuracy medical devices. 'In fact, medtech often requires even greater precision than the semiconductor industry,' she told Bernama. The medtech sector also benefits from its synergies with the electrical and electronics manufacturing sector, as medical devices such as pacemakers, glucose monitoring systems, and diagnostic equipment rely on sophisticated electronic and mechanical components. Loo described the medtech sector as a 'hidden gem' because, unlike the cyclical semiconductor sector, it offers steady growth and higher profit margins, enabling companies to invest more in training talent. 'This stability also attracts talent, as jobs in the sector are less vulnerable to sudden hiring freezes or retrenchments,' she said. Globally, she noted, leading medtech clusters include the United States (US), Ireland, Puerto Rico, and Costa Rica, countries where government support has spurred industry growth over the past decade. In recent years, many companies have expanded into Asia due to rising cost pressures, shifts in policies, and the region's growing, wealthier, and ageing population. She said companies find it attractive to set up operations in Penang when expanding into Asia, thanks to its mature industrial base, skilled workforce, and well-developed supplier network. Moreover, local participation in the sector is also rising, with homegrown firms such as Straits Orthopaedics (Mfg) Sdn Bhd and UWC Healthcare, now serving the global market. Loo said InvestPenang has facilitated the sector's growth by organising exhibitions and engagement sessions with the Health Ministry and industry partners to showcase products and encourage the companies' inclusion in government procurement. However, she noted that medtech companies in Penang face three key challenges: the US Trade Agreements Act, which restricts the value of Malaysian-supplied products in US government contracts; geopolitical tensions and tariffs; and ongoing supply chain disruptions. Despite these hurdles, Loo is optimistic about the prospects over the next five years, and InvestPenang is constantly in talks with several medtech companies about potential investments. 'With Asia's ageing and increasingly affluent population, demand for advanced medical devices is set to rise. We expect to see more global names here, particularly in higher-end products, and we aim to strengthen the role of local companies in this space,' she added. — Bernama
